Novo Nordisk writes more than 9 million prescriptions for weight loss drugs Novo Nordisk writes more than 9 million prescriptions for Wegovy, Ozempic and similar weight loss drugs in the last three months of 2022, according to a report released Wednesday. The report, from analytics firm Trilliant Health, shows a 300% increase in the number of quarterly prescriptions for these weight loss drugs compared to 2020.